Your browser doesn't support javascript.
loading
THE CLINICAL EFFECT OF IRBESARTAN COMBINED WITH ATORVASTATIN ON LEFT VEN-TRICULAR HYPERTROPHY (LVH) IN PATIENTS WITH PRIMARY HYPERTENSION (EH) / 现代医院
Modern Hospital ; (6): 57-58,60, 2014.
Article in Chinese | WPRIM | ID: wpr-604776
ABSTRACT
Objective To discuss the clinical effect of irbesartan combined with atorvastin on LVH in EH patients. Methods 52 EH patients with LVH during December 2010 and December 2012 were chosen as research objects and ran-domly divided into 2 groups.Control group (24 cases) was treated with irbesartan on basis of routine treatment while observa-tion group (28 cases) was treated with irbesartan combined atorvastin on basis of routine treatment.Clinical effects of the 2 groups were observed and compared.Results After treatment, BP and LVMI of the 2 groups both improved obviously and the improvement effect of observation group was better than control group (p<0.05).Clinical effective rate of observation group was 96.43% while control group was 83.33% (p<0.05).Conclusion Irbesartan combined atorvastin is an effective medi-cation method for treatment of LVH of patients with EH and is worth of being popularized in clinical work.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Modern Hospital Year: 2014 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Modern Hospital Year: 2014 Type: Article